Physician profile
Jonathan Vincent Landon
NPI 1902157985
$2,604.81
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2021: $78.45 · 2024: $2,370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $2,340 · Food and Beverage: $30.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $2,340.00 |
| Food and Beverage | $30.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Health Care Systems INC. | $2,340.00 | 2024 | |
| Covidien LP | $142.53 | 2019 | |
| Sientra, INC. | $58.62 | 2021 | |
| Galderma Laboratories, L.P. | $19.83 | 2021 | |
| Merck Sharp & Dohme LLC | $17.33 | 2024 | Bridion |
| Allergan, INC. | $13.64 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $12.86 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Landon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.